Innate Pharma SA (NASDAQ:IPHA)
| 7.60 Delayed Data As of Jan 22 |  +0.09 / +1.20%Today’s Change | 5.61 Today|||52-Week Range 8.24 | +18.01% Year-to-Date |
Latest IPHA News | Press Releases
No recent news for Innate Pharma SA.
Today’s Trading
| Previous close | 7.51 |
| Today’s open | 7.71 |
| Day’s range | 7.50 - 7.71 |
| Volume | 14,246 |
| Average volume (3 months) | 45,975 |
| Market cap | $568.2M |
Data as of 1:32pm ET, 01/22/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -309.59% |
| Earnings growth (next 5 years) | -22.50% |
| Revenue growth (last year) | +156.08% |
| P/E ratio | 13.4 |
| Price/Sales | -- |
| Price/Book | 2.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KURAKura Oncology Inc | -0.04 | -0.32% |
| MGNXMacroGenics Inc | -0.37 | -3.06% |
| ASMBAssembly Biosciences... | -0.18 | -1.03% |
| NLTXNeoleukin Therapeuti... | +0.27 | +2.43% |
Data as of 4:00pm ET, 01/22/2020
Financials
| Next reporting date | March 10, 2020 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $94.3M |
| Annual profit (last year) | $3.6M |
| Net profit margin | 3.82% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
